Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Obesity Stole The Q3 Show

Nov 20 2023

• By Jessica Merrill

Weight loss — • Source: Shutterstock

Related Content

AstraZeneca CEO Soriot On Obesity, Gene Therapy And More

Nov 13 2023

AstraZeneca Moves Into Obesity With Eye On Combinations

Nov 09 2023

The Next Frontier In Obesity: Better, Not More, Weight Loss

Nov 06 2023

Wegovy Buoys Novo Nordisk To Highest-Ever Sales

Nov 02 2023

Lilly Sees Massive Growth For Mounjaro Ahead Of Obesity Approval

Nov 02 2023

‘It’s A Very Different Story,’ Pfizer CEO Bourla Says Of Cuts To Match COVID Revenue

Oct 16 2023

Amgen’s Plan To Go Big In Obesity

Sep 12 2023

Related Companies

Novo Nordisk A/S

Eli Lilly and Company

Pfizer Inc.

Amgen, Inc.

AstraZeneca PLC

Additional Topics

Sales & Earnings Research & Development Growth Metabolic Disorders BioPharmaceutical

More from Growth

More from In Vivo

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.